The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Location status: Recruiting
Location contact
Samantha J Anthony, PhD
CONTACT
416-813-7654 ext. 303126
Samantha J Anthony, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05709132
The iPeer2Peer (iP2P) program is an online peer support mentorship program that provides modelling and reinforcement by trained young adult peer mentors to adolescent mentees with the same condition. A quasi-experimental single-arm pre-post study design will be employed across three sites. We will recruit 40 mentees (12-17 years of age) and 12-15 mentors (18-30 years of age) who will undergo training in mentoring and the use of eHealth technology. Mentor-mentee pairings will connect over 15 weeks through video calls and text messaging to provide peer support and encourage disease self-management skills. Data will be collected using standardized instruments and interviews across three time points.
Interested in participating?
Request Info12 year–30 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M5G 1X8, Canada
Location status: Recruiting
Samantha J Anthony, PhD
CONTACT
416-813-7654 ext. 303126
Samantha J Anthony, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Mentee inclusion criteria:
Mentor inclusion criteria:
Exclusion criteria
Behavioral: iPeer2Peer Support Mentorship Program is an online peer support mentorship program that has been established in multiple chronic disease populations as a self-management intervention, including chronic pain and juvenile idiopathic arthritis. The iPeer2Peer program provides modeling and reinforcement by pre-screened and trained young adult peer mentors to adolescent mentees.
Time frame: 15 weeks after baseline/immediately after the intervention
Whether the innovation is agreeable, palatable or satisfactory
Time frame: Study completion, an average of 1 year
Whether the innovation is agreeable, palatable or satisfactory
Time frame: Baseline to 12 weeks post-program completion
The intention, initial decision or action to try or use an innovation
Time frame: Baseline to study completion, an average of 1 year
The intention, initial decision or action to try or use an innovation
Time frame: Baseline to 12 weeks post-program completion
The extent to which an innovation can be used or carried out successfully in a given setting
Time frame: Baseline to study completion, an average of 1 year
The extent to which an innovation can be used or carried out successfully in a given setting
Time frame: Baseline to 12 weeks post-program completion
The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem
Time frame: Baseline to study completion, an average of 1 year
The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem
Time frame: 15 weeks after baseline/immediately after the intervention
Time frame: Study completion, an average of 1 year
Time frame: Baseline to 12 weeks post-program completion
Time frame: Baseline to 12 weeks post-program completion
Clinic attendance, completion of scheduled tests and procedures, and adolescent medication barriers scale
Time frame: Baseline to 12 weeks post-program completion
Time frame: Baseline to 12 weeks post-program completion
Time frame: Baseline to 12 weeks post-program completion
Time frame: Baseline to 12 weeks post-program completion
Time frame: 15 weeks after baseline/immediately after the intervention
Time frame: Baseline to study completion, an average of 1 year
Time frame: Baseline to study completion, an average of 1 year
Time frame: Baseline to study completion, an average of 1 year
Contact information is provided by the study sponsor or research team.
The Hospital for Sick Children
Other
Implementation and Preliminary Effectiveness Evaluation of the iPeer2Peer Support Mentorship Program for Adolescent and Transitioning Heart Function Patients
Acronym: iP2P HF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06209359
Cardiomyopathies, Cardiovascular Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT06158698
Cardiomyopathies, Cardiovascular Diseases
Naples, Campania, Italy
View Trial DetailsNCT06080074
Cardiogenic Shock, Cardiomyopathies
Palo Alto, California, United States
View Trial DetailsNCT02962661
Cardiomyopathies, Cardiomyopathy
Houston, Texas, United States
View Trial Details